- CNBC’s Jim Cramer explains why the worries of a near-term recession are overblown.
- The “Mad Money” host also sits down with the CEOs of Hasbro, S&P Global and Norfolk Southern.
- In the lightning round, Cramer gives the short and long of it for a gene therapy play.
Lightning round: The long and short of CRSP
In Cramer’s lightning round, he flew through his responses to callers’ stock questions:
Crispr Therapeutics AG: “The short term: it seems to be under pressure a lot. The long term: I like the idea and I think it could go higher. I will say that if you really want to be in that business, you should be buying the stock of Illumina.”
Disclosure: Cramer’s charitable trust owns shares of Amazon.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Questions, comments, suggestions for the “Mad Money” website? email@example.com